Pharmacotherapy of comorbid mood, anxiety, and substance use disorders

被引：29

作者：

Brady, KT ^{[1
]}

Verduin, ML ^{[1
]}

机构：

[1] Med Univ S Carolina, Inst Psychiat, Charleston, SC 29425 USA

来源：

SUBSTANCE USE & MISUSE | 2005年 / 40卷 / 13-14期

关键词：

substance use; mood disorders; anxiety disorders; depression; bipolar disorder; panic disorder; post-traumatic stress disorder; obsessive compulsive disorder; social phobia; alcohol; cocaine; marijuana; opiates;

D O I：

10.1080/10826080500294924

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

Mood and anxiety disorders commonly co-occur with substance use disorders. Exploration of the neurobiology of substance use disorders and mood and anxiety disorders have found that the neural circuitry in mood, anxiety, and substance use disorders is clearly overlapping. These discoveries have encouraged the exploration of a number of pharmacotherapeutic agents in the treatment of co-occurring mood, anxiety, and substance use disorders. In this article, recent data on the pharmacotherapeutic treatment of mood and anxiety disorders in individuals with substance use disorders are reviewed. Some of the barriers to the use of pharmacotherapy in individuals with substance use disorders are discussed.

引用

页码：2021 / 2041

页数：21

共 104 条

[11] Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: preliminary findings [J].

Brady, KT ;

Dansky, BS ;

Back, SE ;

Foa, EB ;

Carroll, KM .

JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2001, 21 (01) :47-54

[12] Carbamazepine in the treatment of cocaine dependence: Subtyping by affective disorder [J].

Brady, KT ;

Sonne, SC ;

Malcolm, RJ ;

Randall, CL ;

Dansky, BS ;

Simpson, K ;

Roberts, JS ;

Brondino, M .

EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2002, 10 (03) :276-285

[13]

BRADY KT, 1995, J CLIN PSYCHIAT, V56, P118

[14]

BRADY KT, 2003, 26 ANN SCI M RES SOC, V845, pA146

[15]

*BRIST MYERS SQUIB, NEF HYDR SERZ PRESCR

[16] Lamotrigine in patients with bipolar disorder and cocaine dependence [J].

Brown, ES ;

Nejtek, VA ;

Perantie, DC ;

Orsulak, PJ ;

Bobadilla, L .

JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (02) :197-201

[17]

BROWN ME, 1986, BIOL PSYCHIAT, V43, P107

[18] Cognitive-behavioral treatment for depression in alcoholism [J].

Brown, RA ;

Evans, DM ;

Miller, IW ;

Burgess, ES ;

Mueller, TI .

JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1997, 65 (05) :715-726

[19]

CHAMBLESS DL, 1987, J ANXIETY DIORD, V1, P29

[20] Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressants [J].

Chengappa, KNR ;

Kambhampati, RK ;

Perkins, K ;

Nigam, R ;

Anderson, T ;

Brar, JS ;

Vemulapalli, HK ;

Atzert, R ;

Key, P ;

Kang, JS ;

Levine, J .

JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (07) :503-508

← 1 2 3 4 5 6 7 8 9 10 →